KEAP1 and cancer: Accordingly, in rapidly dividing cancer cells where ROS production is high [66], or in the process of ageing where there are marked decreases in antioxidant capacity [67], Nrf2, Keap1, and other proteins may be over-oxidized, resulting in dysregulated, and possibly enhanced, antioxidant activity.